by Collectif | 31 Mar, 2016 | Bioethics press synthesis | Embryo research and alternatives
To mark the 10th anniversary of the discovery of iPS cells, Professor Yamanaka[1] has given a lecture in which he announced that induced pluripotent cell research “was about to embark on its second phase” (see Pluripotent cells from adult stem cells). In the...
by Collectif | 31 Mar, 2016 | Bioethics press synthesis | Abortion - Medical termination of Pregnancy(MTP)
In Belgium, an information campaign proposed by the Jongeren Info Life Association “has just been banned and withdrawn from the public domain” following “various challenges”. On the Antwerp trams, posters displayed “a young woman questioning her pregnancy and the...
by Collectif | 30 Mar, 2016 | Bioethics press synthesis | MAP – Surrogacy
Travelling from New Zealand to use the services of two Mexican surrogate mothers who received the eggs of an Argentinian donor, a homosexual couple finally find themselves stuck in Mexico with three babies. The situation of David and Nicky Leonard Beard is...
by Collectif | 30 Mar, 2016 | Bioethics press synthesis | Abortion - Medical termination of Pregnancy(MTP)
The FDA[1] has “relaxed” its recommendations concerning the abortion pill. From now on, the recommended dose of mifepristone is 200 mg (compared to the previous dose of 600 mg). As the dose has been reduced, adverse effects no longer call for mandatory medical...
by Collectif | 29 Mar, 2016 | Bioethics press synthesis | Preimplantation genetic diagnosis
A study published in the Nature journal and directed by Professor Magdalena Zernicka-Goetz shows that “the presence of abnormal cells in premature embryos does not necessarily indicate a deficiency in the unborn baby”. This research has been carried out in mice and it...
by Collectif | 29 Mar, 2016 | Bioethics press synthesis | Prenatal diagnosis
Sequemom has filed a request to transfer its case to the Supreme Court, asking the latter to review a Federal Court decision that non-invasive prenatal screening could not be patented because it failed to meet the required conditions. The question of method...